tiprankstipranks
Trending News
More News >
Aarti Drugs Limited (IN:AARTIDRUGS)
:AARTIDRUGS
India Market

Aarti Drugs Limited (AARTIDRUGS) Income Statement

Compare
3 Followers

Aarti Drugs Limited Income Statement

Last quarter (Q1 2026), Aarti Drugs Limited's total revenue was ₹5.91B, an increase of 6.33% from the same quarter last year. In Q1, Aarti Drugs Limited's net income was ₹539.10M. See Aarti Drugs Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
₹ 23.87B₹ 25.29B₹ 27.16B₹ 24.89B₹ 21.55B
Gross Profit
₹ 8.45B₹ 8.51B₹ 3.69B₹ 3.89B₹ 6.00B
Operating Expenses
₹ 1.12B₹ 1.17B₹ 1.04B₹ 2.06B₹ 2.05B
Depreciation and Amortization
₹ 557.80M₹ 514.47M₹ 503.24M₹ 500.49M₹ 498.83M
EBITDA
₹ 2.87B₹ 3.25B₹ 3.12B₹ 3.44B₹ 4.42B
Operating Income
₹ 7.33B₹ 2.69B₹ 2.65B₹ 2.88B₹ 3.96B
Other Income/Expenses
₹ -5.21B₹ -331.22M₹ 0.00₹ -171.55M₹ -268.77M
Pretax Income
₹ 2.12B₹ 2.36B₹ 2.24B₹ 2.70B₹ 3.69B
Net Income
₹ 1.68B₹ 1.71B₹ 1.66B₹ 2.05B₹ 2.80B
Per Share Metrics
Basic EPS
₹ 18.35₹ 18.56₹ 17.96₹ 22.14₹ 30.09
Diluted EPS
₹ 18.35₹ 18.65₹ 17.96₹ 22.14₹ 30.09
Weighted Average Shares Outstanding
91.64M 92.36M 92.60M 92.60M 93.20M
Weighted Average Shares Outstanding (Diluted)
91.64M 91.94M 92.60M 92.60M 93.20M
Currency in INR

Aarti Drugs Limited Earnings and Revenue History